Redhill Biopharma Ltd
NASDAQ:RDHL
Redhill Biopharma Ltd
NASDAQ:RDHL
Price:
0.98
USD
2.08%
Market Closed
Market Cap:
$5m
Balance Sheet
Balance Sheet Decomposition
Redhill Biopharma Ltd
Redhill Biopharma Ltd
Balance Sheet Decomposition is not available for
Redhill Biopharma Ltd
Redhill Biopharma Ltd
Balance Sheet
Redhill Biopharma Ltd
Redhill Biopharma Ltd
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
7
|
8
|
5
|
6
|
54
|
8
|
8
|
7
|
14
|
29
|
13
|
6
|
2
|
|
| Cash |
7
|
8
|
5
|
6
|
54
|
8
|
8
|
7
|
14
|
29
|
13
|
6
|
2
|
|
| Short-Term Investments |
12
|
4
|
18
|
52
|
12
|
38
|
45
|
41
|
16
|
9
|
7
|
0
|
3
|
|
| Total Receivables |
0
|
0
|
3
|
0
|
0
|
2
|
1
|
1
|
29
|
32
|
35
|
3
|
3
|
|
| Accounts Receivables |
0
|
0
|
3
|
0
|
0
|
2
|
1
|
1
|
29
|
32
|
35
|
3
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
7
|
15
|
11
|
4
|
4
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
2
|
3
|
2
|
2
|
6
|
5
|
20
|
4
|
1
|
|
| Total Current Assets |
19
|
13
|
26
|
61
|
68
|
52
|
57
|
53
|
71
|
89
|
86
|
16
|
12
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
6
|
4
|
7
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
6
|
4
|
7
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
1
|
2
|
3
|
6
|
6
|
5
|
5
|
17
|
88
|
72
|
66
|
6
|
6
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
16
|
0
|
0
|
0
|
|
| Total Assets |
20
N/A
|
14
-29%
|
29
+102%
|
67
+131%
|
74
+11%
|
57
-23%
|
62
+9%
|
74
+19%
|
180
+143%
|
181
+1%
|
159
-12%
|
23
-85%
|
18
-22%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
1
|
0
|
2
|
2
|
6
|
3
|
4
|
29
|
28
|
15
|
3
|
1
|
|
| Accrued Liabilities |
1
|
2
|
2
|
3
|
3
|
6
|
7
|
6
|
24
|
21
|
18
|
5
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
116
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
31
|
48
|
11
|
11
|
|
| Total Current Liabilities |
1
|
2
|
2
|
6
|
5
|
12
|
10
|
11
|
73
|
82
|
198
|
19
|
22
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
85
|
86
|
6
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
2
|
1
|
6
|
0
|
1
|
1
|
8
|
5
|
3
|
1
|
1
|
|
| Total Liabilities |
1
N/A
|
2
+118%
|
4
+58%
|
7
+79%
|
12
+69%
|
12
+7%
|
11
-9%
|
14
+26%
|
166
+1 080%
|
172
+4%
|
207
+20%
|
21
-90%
|
23
+8%
|
|
| Equity | ||||||||||||||
| Common Stock |
8
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
21
|
35
|
|
| Retained Earnings |
21
|
31
|
41
|
61
|
89
|
133
|
169
|
208
|
280
|
368
|
434
|
408
|
415
|
|
| Additional Paid In Capital |
32
|
43
|
66
|
121
|
151
|
177
|
220
|
267
|
293
|
375
|
383
|
388
|
375
|
|
| Total Equity |
19
N/A
|
12
-37%
|
25
+110%
|
60
+140%
|
63
+4%
|
45
-28%
|
51
+14%
|
60
+17%
|
14
-77%
|
9
-36%
|
48
N/A
|
2
N/A
|
5
N/A
|
|
| Total Liabilities & Equity |
20
N/A
|
14
-29%
|
29
+102%
|
67
+131%
|
74
+11%
|
57
-23%
|
62
+9%
|
74
+19%
|
180
+143%
|
181
+1%
|
159
-12%
|
23
-85%
|
18
-22%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
52
|
64
|
88
|
127
|
165
|
213
|
284
|
3 527
|
3 840
|
524
|
932
|
7 870
|
12 900
|
|
Switch to:
Switch to:
See Also
Discover More
